Author Reply to "Intravenous thrombolysis in patients taking direct oral anticoagulants (European stroke organisation intravenous thrombolysis guidelines comment).
作者信息
De Marchis Gian Marco, Turc Guillaume, Whiteley William, Tsivgoulis Georgios
机构信息
Neurology Department and Stroke Center, University Hospital Basel & University of Basel, Basel, Switzerland.
Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Hopital Sainte-Anne, Université de Paris, Paris, France.
出版信息
Eur Stroke J. 2021 Dec;6(4):447-449. doi: 10.1177/23969873211058566. Epub 2021 Nov 15.
Abstract
摘要
相似文献
1
Author Reply to "Intravenous thrombolysis in patients taking direct oral anticoagulants (European stroke organisation intravenous thrombolysis guidelines comment).作者对《正在服用直接口服抗凝剂的患者的静脉溶栓治疗（欧洲卒中组织静脉溶栓指南评论）》的回复
Eur Stroke J. 2021 Dec;6(4):447-449. doi: 10.1177/23969873211058566. Epub 2021 Nov 15.
2
Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.抗凝治疗且不符合静脉溶栓条件的急性缺血性卒中患者血管内血栓切除术的安全性
Cerebrovasc Dis. 2018;46(5-6):193-199. doi: 10.1159/000493801. Epub 2018 Nov 1.
3
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.欧洲卒中组织（ESO）急性缺血性卒中静脉溶栓指南。
Eur Stroke J. 2021 Mar;6(1):I-LXII. doi: 10.1177/2396987321989865. Epub 2021 Feb 19.
4
Intravenous thrombolysis in patients taking direct oral anticoagulants (ESO IVT guidelines comment).服用直接口服抗凝剂患者的静脉溶栓治疗（欧洲卒中组织静脉溶栓指南评论）
Eur Stroke J. 2021 Dec;6(4):445-446. doi: 10.1177/23969873211050848. Epub 2021 Oct 20.
5
Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.服用新型口服抗凝剂的中风患者静脉溶栓治疗的安全性——病例系列及报告病例的系统评价
J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2685-93. doi: 10.1016/j.jstrokecerebrovasdis.2015.07.021. Epub 2015 Nov 2.
6
Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke Onset.预防性低分子肝素剂量下卒中发病患者静脉溶栓的安全性和结局。
Stroke. 2019 May;50(5):1149-1155. doi: 10.1161/STROKEAHA.118.024575.
7
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.直接口服抗凝剂治疗患者静脉溶栓的安全性：系统评价和荟萃分析。
Stroke. 2020 Feb;51(2):533-541. doi: 10.1161/STROKEAHA.119.026426. Epub 2019 Dec 30.
8
Higher efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants-A new relevant hypothesis.直接口服抗凝剂治疗的急性缺血性卒中患者静脉溶栓疗效更高——一个新的相关假说
Front Neurol. 2024 Sep 6;15:1458697. doi: 10.3389/fneur.2024.1458697. eCollection 2024.
9
Thrombolysis in Patients Aged over 80 Years Is Equally Effective and Safe.80岁以上患者的溶栓治疗同样有效且安全。
J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1532-8. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.007. Epub 2016 Apr 1.
10
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.直接口服抗凝剂治疗的急性缺血性脑卒中患者的静脉溶栓治疗。
Eur J Neurol. 2018 May;25(5):747-e52. doi: 10.1111/ene.13582. Epub 2018 Mar 9.
本文引用的文献
1
Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage.模拟抗因子 Xa 抑制剂相关性脑出血中andexanet alfa 的临床意义。
Neurology. 2021 Nov 23;97(21):e2054-e2064. doi: 10.1212/WNL.0000000000012856. Epub 2021 Sep 23.
2
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.欧洲卒中组织（ESO）急性缺血性卒中静脉溶栓指南。
Eur Stroke J. 2021 Mar;6(1):I-LXII. doi: 10.1177/2396987321989865. Epub 2021 Feb 19.
3
The Magic of Randomization versus the Myth of Real-World Evidence.随机化的魔力与真实世界证据的神话
N Engl J Med. 2020 Feb 13;382(7):674-678. doi: 10.1056/NEJMsb1901642.
4
Monitoring of low dabigatran concentrations: diagnostic performance at clinically relevant decision thresholds.监测低达比加群浓度：在临床相关决策阈值下的诊断性能。
J Thromb Thrombolysis. 2020 Apr;49(3):457-467. doi: 10.1007/s11239-019-01981-z.
5
Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke.直接口服抗凝剂的血浆水平在急性缺血性脑卒中治疗中的应用。
Cerebrovasc Dis. 2019;48(1-2):17-25. doi: 10.1159/000502335. Epub 2019 Sep 4.
6
Using an old test for new tricks: Measuring direct oral anti-Xa drug levels by conventional heparin-calibrated anti-Xa assay.旧瓶装新酒：采用传统肝素校准的抗Xa测定法测量直接口服抗Xa药物水平
Am J Hematol. 2019 May;94(5):E132-E134. doi: 10.1002/ajh.25434. Epub 2019 Feb 21.
7
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.依达赛珠单抗治疗与因子 Xa 抑制剂相关出血的完整研究报告。
N Engl J Med. 2019 Apr 4;380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7.
8
Testing and monitoring direct oral anticoagulants.检测和监测直接口服抗凝剂。
Blood. 2018 Nov 8;132(19):2009-2015. doi: 10.1182/blood-2018-04-791541. Epub 2018 Sep 10.
9
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.直接口服抗凝剂治疗的急性缺血性脑卒中患者的静脉溶栓治疗。
Eur J Neurol. 2018 May;25(5):747-e52. doi: 10.1111/ene.13582. Epub 2018 Mar 9.
10
Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study.直接口服抗凝剂术前浓度的预测因素：一项前瞻性多中心研究。
Eur Heart J. 2017 Aug 14;38(31):2431-2439. doi: 10.1093/eurheartj/ehx403.
Zotero 插件